| Year |
Citation |
Score |
| 2018 |
Yang X, Yu X, Wei Y. Lentiviral delivery of novel fusion protein IL12/FasTI for cancer immune/gene therapy. Plos One. 13: e0201100. PMID 30044833 DOI: 10.1371/Journal.Pone.0201100 |
0.51 |
|
| 2018 |
Yang X, Kuang S, Wang L, Wei Y. MHC class I chain-related A: Polymorphism, regulation and therapeutic value in cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 103: 111-117. PMID 29635123 DOI: 10.1016/J.Biopha.2018.03.177 |
0.429 |
|
| 2018 |
Ding H, Yang X, Wei Y. Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy. International Journal of Molecular Sciences. 19. PMID 29316666 DOI: 10.3390/Ijms19010177 |
0.434 |
|
| 2017 |
Tietje A, Yang X, Yu X, Wei Y. MICA/IL-12: A novel bifunctional protein for killer cell activation. Oncology Reports. PMID 28098874 DOI: 10.3892/Or.2017.5375 |
0.466 |
|
| 2016 |
Dong Y, Li Y, Wei YL, Wang JC, Ma JP, Ji J, Yao BJ, Dong YB. A N-heterocyclic tetracarbene Pd(ii) moiety containing a Pd(ii)-Pb(ii) bimetallic MOF for three-component cyclotrimerization via benzyne. Chemical Communications (Cambridge, England). PMID 27489026 DOI: 10.1039/c6cc04570g |
0.524 |
|
| 2016 |
Wei Y, Zhang K, Garzione CN, Xu Y, Song B, Ji J. Low palaeoelevation of the northern Lhasa terrane during late Eocene: Fossil foraminifera and stable isotope evidence from the Gerze Basin. Scientific Reports. 6: 27508. PMID 27272610 DOI: 10.1038/Srep27508 |
0.528 |
|
| 2016 |
Yang X, Tietje AH, Yu X, Wei Y. Mouse interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immuno/gene therapy. International Journal of Oncology. PMID 27081758 DOI: 10.3892/Ijo.2016.3475 |
0.481 |
|
| 2016 |
Jenkins R, Bandera YP, Daniele MA, Ledford LL, Tietje A, Kelso AA, Sehorn MG, Wei Y, Chakrabarti M, Ray SK, Foulger SH. Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells. Biomaterials Science. PMID 26845086 DOI: 10.1039/C5Bm00580A |
0.356 |
|
| 2016 |
Yang X, Tietje A, Yu X, Wei Y. Abstract 4874: Interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immunotherapy Cancer Research. 76: 4874-4874. DOI: 10.1158/1538-7445.Am2016-4874 |
0.484 |
|
| 2015 |
Wei Y, Zhang JX, Ji Y, Ji J. REDV/Rapamycin-loaded polymer combinations as a coordinated strategy to enhance endothelial cells selectivity for a stent system. Colloids and Surfaces. B, Biointerfaces. PMID 26613858 DOI: 10.1016/J.Colsurfb.2015.11.012 |
0.58 |
|
| 2015 |
Chen T, Gao J, Xiang P, Chen Y, Ji J, Xie P, Wu H, Xiao W, Wei Y, Wang S, Lan L, Ji H, Yan T. Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance. International Immunopharmacology. 26: 338-48. PMID 25887267 DOI: 10.1016/j.intimp.2015.04.001 |
0.583 |
|
| 2015 |
Sang S, Wang Y, Feng Q, Wei Y, Ji J, Zhang W. Progress of new label-free techniques for biosensors: a review. Critical Reviews in Biotechnology. 1-17. PMID 25608959 DOI: 10.3109/07388551.2014.991270 |
0.544 |
|
| 2014 |
Li J, Yu X, Wagner TE, Wei Y. A biotin-streptavidin-biotin bridge dramatically enhances cell fusion. Oncology Letters. 8: 198-202. PMID 24959245 DOI: 10.3892/Ol.2014.2067 |
0.553 |
|
| 2014 |
Tietje A, Li J, Yu X, Wei Y. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. Gene Therapy. 21: 468-475. PMID 24572784 DOI: 10.1038/Gt.2014.15 |
0.473 |
|
| 2013 |
Li J, Chang LC, Wall M, Wong DK, Yu X, Wei Y. Antitumor activity of fermented noni exudates and its fractions. Molecular and Clinical Oncology. 1: 161-164. PMID 24649140 DOI: 10.3892/Mco.2012.24 |
0.41 |
|
| 2013 |
Wei Y, Ji Y, Xiao LL, Lin QK, Xu JP, Ren KF, Ji J. Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation. Biomaterials. 34: 2588-99. PMID 23352039 DOI: 10.1016/J.Biomaterials.2012.12.036 |
0.617 |
|
| 2013 |
Tietje AH, Li J, Yu X, Wei Y. Abstract 488: MULT1E/mIL-12: A novel bi-functional protein for NK cell activation. Cancer Research. 73: 488-488. DOI: 10.1158/1538-7445.Am2013-488 |
0.468 |
|
| 2012 |
Wen XZ, Chen ZH, Wei YZ, Ji JF. Evolution of viral RNA in a Chinese patient to interferon/ribavirin therapy for hepatitis C. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 24: 353-60. PMID 23359634 DOI: 10.3978/j.issn.1000-9604.2012.10.01 |
0.532 |
|
| 2012 |
Zhu L, Zhao Z, Wei Y, Marcotte W, Wagner TE, Yu X. An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation. International Journal of Oncology. 41: 661-9. PMID 22581115 DOI: 10.3892/Ijo.2012.1466 |
0.565 |
|
| 2012 |
Ji Y, Wei Y, Liu X, Wang J, Ren K, Ji J. Zwitterionic polycarboxybetaine coating functionalized with REDV peptide to improve selectivity for endothelial cells. Journal of Biomedical Materials Research. Part A. 100: 1387-97. PMID 22374807 DOI: 10.1002/Jbm.A.34077 |
0.599 |
|
| 2012 |
Zhao Z, Holle L, Song W, Wei Y, Wagner TE, Yu X. Antitumor and anti-angiogenic activities of Scutellaria barbata extracts in vitro are partially mediated by inhibition of Akt/protein kinase B. Molecular Medicine Reports. 5: 788-92. PMID 22160152 DOI: 10.3892/Mmr.2011.694 |
0.483 |
|
| 2011 |
Kim JY, Wei Y, Li J, Foy P, Hawkins T, Ballato J, Kim SO. Single-cell-level microplasma cancer therapy. Small (Weinheim An Der Bergstrasse, Germany). 7: 2291-5. PMID 21661106 DOI: 10.1002/Smll.201100456 |
0.325 |
|
| 2011 |
Wei Y, Ji Y, Xiao L, Lin Q, Ji J. Different complex surfaces of polyethyleneglycol (PEG) and REDV ligand to enhance the endothelial cells selectivity over smooth muscle cells. Colloids and Surfaces. B, Biointerfaces. 84: 369-78. PMID 21333506 DOI: 10.1016/J.Colsurfb.2011.01.028 |
0.599 |
|
| 2011 |
Zhu L, Wei Y, Yu X. Abstract A68: An IL-12/Shh-C domain fusion protein based IL-12 autocrine loop for sustained natural killer cell activation Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A68 |
0.369 |
|
| 2011 |
Kim JY, Ballato J, Foy P, Hawkins T, Wei Y, Li J, Kim S. Apoptosis Experiments of Cultured Tumor Cells Treated With 200- $\mu\hbox{m}$-Sized Flexible Microplasma Jet Ieee Transactions On Plasma Science. 39: 2974-2975. DOI: 10.1109/Tps.2011.2134111 |
0.396 |
|
| 2010 |
Xu JP, Yang X, Lv LP, Wei Y, Xu FM, Ji J. Gold-nanoparticle-stabilized pluronic micelles exhibiting glutathione triggered morphology evolution properties. Langmuir : the Acs Journal of Surfaces and Colloids. 26: 16841-7. PMID 20942438 DOI: 10.1021/La102929K |
0.535 |
|
| 2010 |
Kim JY, Wei Y, Li J, Kim SO. 15-μm-sized single-cellular-level and cell-manipulatable microplasma jet in cancer therapies. Biosensors & Bioelectronics. 26: 555-9. PMID 20685106 DOI: 10.1016/J.Bios.2010.07.043 |
0.407 |
|
| 2010 |
Kim JY, Ballato J, Foy P, Hawkins T, Wei Y, Li J, Kim SO. Single-cell-level cancer therapy using a hollow optical fiber-based microplasma. Small (Weinheim An Der Bergstrasse, Germany). 6: 1474-8. PMID 20586057 DOI: 10.1002/Smll.201000480 |
0.34 |
|
| 2010 |
Branham-O'Connor M, Li J, Kotturi HS, Yu X, Wagner TE, Wei Y. Fusion induced reversal of dendritic cell maturation: an altered expression of inflammatory chemokine and chemokine receptors in dendritomas. Oncology Reports. 23: 545-50. PMID 20043120 DOI: 10.3892/Or_00000668 |
0.754 |
|
| 2010 |
Kotturi HS, Li J, Branham-O'Connor M, Yu X, Wagner TE, Wei Y. In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors. Cancer Gene Therapy. 17: 164-70. PMID 19816522 DOI: 10.1038/Cgt.2009.69 |
0.77 |
|
| 2010 |
Zhang X, Thorne R, Wagner T, Wei Y. Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope Current Cancer Therapy Reviews. 6: 34-40. DOI: 10.2174/157339410790596470 |
0.485 |
|
| 2010 |
Kim JY, Kim S, Wei Y, Li J. A flexible cold microplasma jet using biocompatible dielectric tubes for cancer therapy Applied Physics Letters. 96: 203701. DOI: 10.1063/1.3431392 |
0.394 |
|
| 2009 |
Zhang X, Li J, Wong DK, Wagner TE, Wei Y. Fermented Noni Exudate-treated dendritic cells directly stimulate B lymphocyte proliferation and differentiation. Oncology Reports. 21: 1147-52. PMID 19360287 DOI: 10.3892/Or_00000334 |
0.53 |
|
| 2009 |
Li J, King AV, Stickel SL, Burgin KE, Zhang X, Wagner TE, Wei Y. Whole tumor cell vaccine with irradiated S180 cells as adjuvant. Vaccine. 27: 558-64. PMID 19027812 DOI: 10.1016/J.Vaccine.2008.11.014 |
0.568 |
|
| 2009 |
Wei Y, Li J, Wagner T. Dendritoma Vaccine for Cancer: A Hopeful Approach Current Cancer Therapy Reviews. 5: 134-141. DOI: 10.2174/157339409788166724 |
0.439 |
|
| 2008 |
Li J, Stickel SL, Bouton-Verville H, Burgin KE, Yu X, Wong DK, Wagner TE, Wei Y. Fermented Noni exudate (fNE): a mediator between immune system and anti-tumor activity. Oncology Reports. 20: 1505-9. PMID 19020734 DOI: 10.3892/Or_00000172 |
0.583 |
|
| 2008 |
Zhang B, Zhang R, Ji J, Xue K, Jing E, Zhang Z, Wei Y. [Cloning of human adiponectin gene by PCR-driven overlap extension and expression in Pichia pastoris]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 24: 1480-4. PMID 18998555 |
0.589 |
|
| 2008 |
Wei Y, Weng D, Li F, Zou X, Young DO, Ji J, Shen P. Involvement of JNK regulation in oxidative stress-mediated murine liver injury by microcystin-LR. Apoptosis : An International Journal On Programmed Cell Death. 13: 1031-42. PMID 18594987 DOI: 10.1007/s10495-008-0237-2 |
0.541 |
|
| 2008 |
Kotturi HS, Li J, Branham-O'Connor M, Stickel SL, Yu X, Wagner TE, Wei Y. Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation. Gene Therapy. 15: 1302-10. PMID 18463688 DOI: 10.1038/Gt.2008.77 |
0.775 |
|
| 2008 |
An Y, Ji J, Wu W, Huang R, Wei Y, Xiu Z. Random mutagenesis and recombination of sam1 gene by integrating error-prone PCR with staggered extension process. Biotechnology Letters. 30: 1227-32. PMID 18317700 DOI: 10.1007/s10529-008-9674-9 |
0.559 |
|
| 2008 |
Craig DH, Wei Y, Basson MD. W1970 Increased Extracellular Pressure Enhances Cancer Cell β1-Integrin Binding Affinity Through Phosphorylation of β1-Integrin At Threonine 788/789 Gastroenterology. 134: A-745. DOI: 10.1016/S0016-5085(08)63477-0 |
0.307 |
|
| 2007 |
Ni J, Ji J, Bai X, Lu A, Huang R, Wei Y, Wu W. [Construction and expression of anti-GD2/anti-CD16 single-chain bispecific antibody]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 24: 659-63. PMID 17713283 |
0.586 |
|
| 2007 |
Wei YC, Sticca RP, Li J, Holmes LM, Burgin KE, Jakubchak S, Bouton-Verville H, Williamson J, Meyer K, Evans L, Martin J, Stephenson JJ, Trocha S, Smith S, Wagner TE. Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study. Oncology Reports. 18: 665-71. PMID 17671717 DOI: 10.3892/Or.18.3.665 |
0.512 |
|
| 2007 |
Li J, Theofanous L, Stickel S, Bouton-Verville H, Burgin KE, Jakubchak S, Wagner TE, Wei Y. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells. International Journal of Oncology. 31: 193-7. PMID 17549421 DOI: 10.3892/Ijo.31.1.193 |
0.599 |
|
| 2007 |
Ni J, Ji J, Lü A, Huang R, Wei Y, Wu W. [Construction and expression of an anti-GD2,ScFv-IL-2 fusion protein gene]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 24: 170-5. PMID 17333916 |
0.629 |
|
| 2007 |
Wei YC, Stephenson JJ, Li J, Burgin KE, Bouton-Verville H, Jakubchak S, Holmes LM, Meyer K, Martin J, Trocha SD, Wagner TE. A phase II clinical study of dendritoma vaccination combined with low dose interleukin-2 in advanced melanoma patients Journal of Clinical Oncology. 25: 3051-3051. DOI: 10.1200/Jco.2007.25.18_Suppl.3051 |
0.468 |
|
| 2006 |
Wei Y, Sticca RP, Holmes LM, Burgin KE, Li J, Williamson J, Evans L, Smith SJ, Stephenson JJ, Wagner TE. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses. International Journal of Oncology. 28: 585-93. PMID 16465362 DOI: 10.3892/Ijo.28.3.585 |
0.468 |
|
| 2005 |
Qi Y, Zhu X, Lou Q, Ji J, Dong J, Wei Y. Nd:YAG ceramic laser obtained high slope-efficiency of 62% in high power applications. Optics Express. 13: 8725-9. PMID 19498905 DOI: 10.1364/OPEX.13.008725 |
0.529 |
|
| 2005 |
An Y, Ji J, Wu W, Lv A, Huang R, Wei Y. A rapid and efficient method for multiple-site mutagenesis with a modified overlap extension PCR. Applied Microbiology and Biotechnology. 68: 774-8. PMID 16249879 DOI: 10.1007/s00253-005-1948-8 |
0.545 |
|
| 2004 |
Li J, Bouton-Verville H, Holmes LM, Burgin KE, Jakubchak S, Yu X, Wagner TE, Wei Y. Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent. Anticancer Research. 24: 2717-21. PMID 15517877 |
0.495 |
|
| 2004 |
Ji J, Li J, Holmes LM, Burgin KE, Yu X, Wagner TE, Wei Y. Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12. The Journal of Gene Medicine. 6: 777-85. PMID 15241785 DOI: 10.1002/Jgm.547 |
0.676 |
|
| 2004 |
Li J, Ji J, Holmes LM, Burgin KE, Barton LB, Yu X, Wagner TE, Wei Y. Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor. Cancer Gene Therapy. 11: 363-70. PMID 15044960 DOI: 10.1038/Sj.Cgt.7700707 |
0.717 |
|
| 2004 |
Holle L, Song W, Hicks L, Holle E, Holmes L, Wei Y, Li J, Wagner T, Yu X. In vitro targeted killing of human endothelial cells by co-incubation of human serum and NGR peptide conjugated human albumin protein bearing alpha (1-3) galactose epitopes. Oncology Reports. 11: 613-6. PMID 14767511 DOI: 10.3892/Or.11.3.613 |
0.517 |
|
| 2003 |
Li J, Franek KJ, Patterson AL, Holmes LM, Burgin KE, Ji J, Yu X, Wagner TE, Wei Y. Targeting foreign major histocompatibility complex molecules to tumors by tumor cell specific single chain antibody (scFv). International Journal of Oncology. 23: 1329-32. PMID 14532973 DOI: 10.3892/Ijo.23.5.1329 |
0.749 |
|
| 2003 |
Holle L, Song W, Holle E, Wei Y, Wagner T, Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. International Journal of Oncology. 22: 93-8. PMID 12469190 DOI: 10.3892/Ijo.22.1.93 |
0.568 |
|
| 2002 |
Ji J, Li J, Holmes LM, Burgin KE, Yu X, Wagner TE, Wei Y. Glycoinositol phospholipid-anchored interleukin 2 but not secreted interleukin 2 inhibits melanoma tumor growth in mice. Molecular Cancer Therapeutics. 1: 1019-24. PMID 12481424 |
0.725 |
|
| 2001 |
Holmes LM, Li J, Sticca RP, Wagner TE, Wei Y. A Rapid, Novel Strategy to Induce Tumor Cell-Specific Cytotoxic T Lymphocyte Responses Using Instant Dendritomas. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 24: 122-129. PMID 11449068 DOI: 10.1097/00002371-200103000-00006 |
0.614 |
|
| 2000 |
Li J, Holmes LM, Franek KJ, Wagner TE, Wei Y. Murine tyrosinase expressed by a T7 vector in bone marrow-derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice. Cancer Gene Therapy. 7: 1448-55. PMID 11129287 DOI: 10.1038/Sj.Cgt.7700260 |
0.599 |
|
| 2000 |
Wei Y, Li J, Chen WY, Yu X, Sticca RP, Wagner TE. Enhanced transgene expression and effective in vivo antitumor immune responses initiated by dendritic progenitors transfected with a nonviral T7 vector expressing a model tumor antigen. Journal of Immunotherapy (Hagerstown, Md. : 1997). 23: 75-82. PMID 10687140 DOI: 10.1097/00002371-200001000-00010 |
0.536 |
|
| Show low-probability matches. |
